Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 7
2017 10
2018 6
2019 7
2020 4
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers.
Mapelli P, Callea M, Fallanca F, Castellano A, Bailo M, Scifo P, Bettinardi V, Conte GM, Monterisi C, Rancoita PMV, Incerti E, Vuozzo M, Gianolli L, Terreni M, Anzalone N, Picchio M. Mapelli P, et al. Among authors: incerti e. Nucl Med Commun. 2021 Jul 1;42(7):763-771. doi: 10.1097/MNM.0000000000001396. Nucl Med Commun. 2021. PMID: 33741855
Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic cancer.
Mori M, Passoni P, Incerti E, Bettinardi V, Broggi S, Reni M, Whybra P, Spezi E, Vanoli EG, Gianolli L, Picchio M, Di Muzio NG, Fiorino C. Mori M, et al. Among authors: incerti e. Radiother Oncol. 2020 Dec;153:258-264. doi: 10.1016/j.radonc.2020.07.003. Epub 2020 Jul 15. Radiother Oncol. 2020. PMID: 32681930 Free article.
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial.
Capitanio U, Pepe G, Incerti E, Larcher A, Trevisani F, Lucianò R, Mapelli P, Bettinardi V, Monterisi C, Necchi A, Cascinu S, Bernardi R, Bertini R, Doglioni C, Gianolli L, Salonia A, Picchio M, Montorsi F. Capitanio U, et al. Among authors: incerti e. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):554-560. doi: 10.1007/s00259-020-04936-2. Epub 2020 Jul 8. Eur J Nucl Med Mol Imaging. 2021. PMID: 32638098
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients.
Incerti E, Vanoli EG, Broggi S, Gumina C, Passoni P, Slim N, Fiorino C, Reni M, Mapelli P, Cattaneo M, Zanon S, Calandrino R, Gianolli L, Di Muzio N, Picchio M. Incerti E, et al. Nucl Med Commun. 2019 Oct;40(10):1072-1080. doi: 10.1097/MNM.0000000000001065. Nucl Med Commun. 2019. PMID: 31365502
18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study.
Zattoni F, Incerti E, Dal Moro F, Moschini M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Gallina A, Fanti S, Schiavina R, Brunocilla E, Rambaldi I, Lowe V, Karnes JR, Evangelista L. Zattoni F, et al. Among authors: incerti e. Cancers (Basel). 2019 May 20;11(5):700. doi: 10.3390/cancers11050700. Cancers (Basel). 2019. PMID: 31137599 Free PMC article.
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml.
Giovacchini G, Guglielmo P, Mapelli P, Incerti E, Gajate AMS, Giovannini E, Riondato M, Briganti A, Gianolli L, Ciarmiello A, Picchio M. Giovacchini G, et al. Among authors: incerti e. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):921-929. doi: 10.1007/s00259-018-4253-3. Epub 2019 Jan 10. Eur J Nucl Med Mol Imaging. 2019. PMID: 30631911
34 results